In:
European Journal of Preventive Cardiology, Oxford University Press (OUP), Vol. 30, No. Supplement_1 ( 2023-05-24)
Abstract:
Type of funding sources: None. Background In 2020, the Japanese government issued a new policy to facilitate telemedicine to prevent spread of SARS-Cov-2 infection in outpatient of medical facilities. This policy included consultation via telephone or web and issuing prescriptions directly to pharmacies. However, the patients with diabetes mellites usually have few symptoms. Accordingly, evaluation of control status and medical feedback is difficult on telemedicine basis. We sought to evaluate the impact of telemedicine on the treatment of DM in patients with cardiovascular disease during SARS-Cov-2 Pandemic period. Method Between April and Oct 2020, 165 patients with cardiovascular disease having diabetes mellites utilized telemedicine. We retrospectively analyzed indices of patients’ condition and compared them before and after telemedicine. These indices included serum blood sugar, hemoglobin A1c, HDL, LDL cholesterol and triglyceride. Result Mean age of the patients was 74.0 ± 9.6 years. Average interval of telemedicine was 6.6 ± 3.4 months. The value of HbA1c before and after telemedicine period was 6.7 ± 0.9 and 7.0 ± 1.2 % respectively (p=0.006). No statistical difference was observed in systolic/diastolic blood pressure, HDL LDL cholesterol and triglyceride during same period. Conclusion In telemedicine for the patients with cardiovascular disease, additional caution is needed when patients had concomitant diabetes mellites.
Type of Medium:
Online Resource
ISSN:
2047-4873
,
2047-4881
DOI:
10.1093/eurjpc/zwad125.221
Language:
English
Publisher:
Oxford University Press (OUP)
Publication Date:
2023
detail.hit.zdb_id:
2646239-4
Permalink